Barclays Starts Tilray (TLRY) at Underweight
- Wall Street ends sharply higher as Treasury yields dip
- Apple Falls 4% on Report It Will Not Ramp Up iPhone 14 Production, Analyst Not Surprised
- Biogen (BIIB) Surges After 'Best-Case' Alzheimer's Drug Trial Results; Stock Earns Several Upgrades
- Europe Stock Outflows 'Worse Than During COVID Panic' - Citi
- Oil up 4% as Bulls Storm Back In on Hurricane, Crude Draw and Dollar Drop
Barclays analyst Gaurav Jain initiates coverage on Tilray (NASDAQ: TLRY) with a Underweight rating and a price target of $10.00.
Shares of Tilray closed at $12.34 yesterday.
You May Also Be Interested In
- SweetWater Brewing Company Unveils New Fall Craft-Beer Releases
- Truist Securities Assumes Tesla (TSLA) at Buy
- UPDATE: Baird Starts CNH Industrial NV (CNHI) at Outperform
Create E-mail Alert Related CategoriesNew Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!